⏳ Fetching live dividend data...
Home › Calculator › LPCN Dividend Calculator 2026
Lipocine Inc. · NASDAQ
Price: $2.21 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in LPCN → $6.29M in 10 years · $249,152.29/month
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone replacement therapy. The company's pipeline candidates also include LPCN 1144, an oral prodrug of bioidentical testosterone that has completed Phase II clinical trial for the treatment of non-cirrhotic non-alcoholic steatohepatitis; LPCN 1111, an oral prodrug of testosterone tridecanoate for once daily dosing, which has completed Phase II clinical trial in hypogonadal men; LPCN 1148, a novel prodrug of testosterone and testosterone laurate for the management of decompensated cirrhosis; LPCN 1154, an investigational new drug application to conduct a Phase 2 study in Postpartum depression; LPCN 2101 for women with epilepsy, which has completed pre-clinical study; and LPCN 1107, an oral hydroxyprogesterone caproate product that has completed dose finding Phase II clinical trial for the prevention of recurrent preterm birth. The company is headquartered in Salt Lake City, Utah.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open LPCN position with:
Real after-tax yield depends on where you live and how you hold LPCN.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 90.50% | 87.70% | $9,050 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 76.92% | 74.13% | $7,693 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 72.40% | 69.60% | $7,240 / yr |
| 🇬🇧 UK ISA | 0% | 90.50% | 87.70% | $9,050 / yr |
| 🇬🇧 UK Taxable | 8.75% | 82.58% | 79.78% | $8,258 / yr |
| 🇨🇦 TFSA | 0% | 90.50% | 87.70% | $9,050 / yr |
| 🇨🇦 CA Taxable | 25% | 67.88% | 65.08% | $6,788 / yr |
| 🇦🇺 Super (pension) | 15% | 76.92% | 74.13% | $7,693 / yr |
| 🇦🇺 AU Taxable | 30% | 63.35% | 60.55% | $6,335 / yr |
| 🇩🇪 DE Taxable | 26.375% | 66.63% | 63.83% | $6,663 / yr |
| 🇫🇷 FR Taxable | 30% | 63.35% | 60.55% | $6,335 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
LPCN pays quarterly — 4 times per year. Next ex-div: TBD.
How LPCN compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for LPCN sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-06-03 | 1,764 | $2.19 | $3.9K | ||
| A-Award | 2026-06-03 | 1,764 | $2.19 | $3.9K | ||
| A-Award | 2026-06-03 | 1,764 | $2.19 | $3.9K | ||
| Buy | 2026-04-07 | 40,000 | $2.03 | $81.2K | ||
| Buy | 2026-04-06 | 123,000 | $2.05 | $252.2K | ||
| Buy | 2026-04-06 | 25,000 | $2.03 | $50.8K | ||
| Buy | 2026-04-02 | 25,000 | $2.02 | $50.5K | ||
| A-Award | 2026-01-02 | 25,000 | $8.00 | $200.0K | ||
| A-Award | 2025-12-18 | 8,629 | $4.20 | $36.2K | ||
| A-Award | 2025-12-18 | 20,786 | $4.20 | $87.3K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Insiders are net buyers — historically a positive signal for dividend sustainability. Last purchase: 2026-04-07
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the LPCN dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →